Evidence map›Paper›PMID 38324466›Full record

ArticleNucleic acids research2024

Cross-contamination of CRISPR guides and other unrelated nucleotide sequences among commercial oligonucleotides.

Hiroshi Arakawa, Hiromi Miura, Rolen M Quadros, Masato Ohtsuka, Channabasavaiah B Gurumurthy

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroshi ArakawaIFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0002-8103-4549
Hiromi MiuraDivision of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa Japan.
Rolen M QuadrosMouse Genome Engineering Core Facility, University of Nebraska Medical Center, Omaha, NE, USA.
Masato OhtsukaDivision of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa Japan.
Channabasavaiah B GurumurthyMouse Genome Engineering Core Facility, University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0002-8022-4033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Custom oligonucleotides (oligos) are widely used reagents in biomedical research. Some common applications of oligos include polymerase chain reaction (PCR), sequencing, hybridization, microarray, and library construction. The reliability of oligos in such applications depends on their purity and specificity. Here, we report that commercially available oligos are frequently contaminated with nonspecific sequences (i.e. other unrelated oligonucleotides). Most of the oligos that we designed to amplify clustered regularly interspersed palindromic repeats (CRISPR) guide sequences contained nonspecific CRISPR guides. These contaminants were detected in research-grade oligos procured from eight commercial oligo-suppliers located in three different geographic regions of the world. Deep sequencing of some of the oligos revealed a variety of contaminants. Given the wide range of applications of oligos, the impact of oligo cross-contamination varies greatly depending on the field and the experimental method. Incorporating appropriate control experiments in research design can help ensure that the quality of oligo reagents meets the intended purpose. This can also minimize risk depending on the purposes for which the oligos are used.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsDrug ContaminationIndicators and ReagentsOligonucleotidesBase SequenceGenetic TechniquesIndustryIndicators and ReagentsOligonucleotides

Identifiers

PMID38324466
PMCPMC11014326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.